Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Richard Schlemmer"'
Publikováno v:
Archiv der Pharmazie. 334:309-317
In female B6D2F1 mice bearing an MXT-M-3,2 breast cancer graft the level of the phagocytic cells (e.g. of granulocytes and macrophages in the spleen and of granulocytes and monocytes in the blood) is significantly elevated. The positive correlation b
Publikováno v:
Archiv der Pharmazie. 333:397-403
The anti-tumor activity of [meso-1,2-bis(2,6-dichloro-4- hydroxyphenyl)ethylenediamine]dichloroplatinum(II) on the MXT-M-3,2 breast cancer implanted into B6D2F1 mice was not significantly reduced by splenectomy or co-administration of cyclosporine A.
Publikováno v:
Archiv der Pharmazie. 333:404-414
MXT-M-3,2 breast cancer implanted into female B6D2F1 mice accelerates the growth of an identical second tumor. This process is accompanied by a significant increase of the granulocyte and monocyte numbers in the blood and of the granulocyte and macro
Publikováno v:
ChemInform. 30
Autor:
Richard Schlemmer, H. Schoenenberger, Ronald Gust, Sabine Schertl, Rolf W. Hartmann, Thilo Spruss, Christine Batzl-Hartmann, Guenther Bernhardt
Publikováno v:
ChemInform. 32
Publikováno v:
Archiv der Pharmazie. 333:69-71
The MXT-M-3.2 breast cancer implanted into female B6D2F1 mice accelerates the growth of an identical second tumor. This process is inhibited by [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl) ethylenediamine]dichloroplatinum(II). The possible modes of ac
Autor:
Thilo Spruß, Helmut Schönenberger, Christine Batzl-Hartmann, Rolf W. Hartmann, Marion Koch, Rudolf Krauser, Karin Beckenlehner, Sabine Schertl, Ronald Gust, Richard Schlemmer, Günther Bernhardt
Publikováno v:
Archiv der Pharmazie. 337(6)
Aqua[meso-1, 2-bis(2, 6-difluoro-3-hydroxyphenyl)ethylenediamine]sulfatoplatinum(II) (meso-3-PtSO(4)) and its racemate (rac-3-PtSO(4)) are highly active on the hormone-sensitive MXT-M-3, 2 breast cancer of the mouse. In vitro, on the MXT(+) cell cult
Autor:
Rolf W. Hartmann, Marion Koch, Ronald Gust, Richard Schlemmer, Rudolf Krauser, Christine Batzl-Hartmann, Sabine Schertl, Thilo Spruss, Helmut Schönenberger, Günther Bernhardt, Karin Beckenlehner
Publikováno v:
Archiv der Pharmazie. 337(6)
The marked activity of [meso-1, 2-bis(2, 6-difluoro-3-hydroxyphenyl)ethylenediamine]platinum(II) (meso-3-PtLL', L, L' = Cl(2) or L = OH(2), L' = OSO(3)) on the hormone-sensitive MXT-M-3, 2 breast cancer implanted in mice is most probably due to a mec
Autor:
Herta Reile, Karin Beckenlehner, Richard Schlemmer, Helmut Schönenberger, Thilo Spruss, Günther Bernhardt
Publikováno v:
Archiv der Pharmazie. 335(2)
The establishment of two new breast cancer cell lines, MXT(+) and MXT(-), derived from the murine breast cancer models MXT-M-3, 2 MC (hormone-sensitive) and MXT-M-3, 2 (ovex) MC (hormone-insensitive), is described. Characterization of the cell lines
Autor:
Rolf W. Hartmann, Günther Bernhardt, Helmut Schönenberger, Sabine Schertl, Richard Schlemmer, Thilo Spruß, Ronald Gust, Christine Batzl-Hartmann
Publikováno v:
Archiv der Pharmazie. 334(4)
[meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]platinum(II) complexes (meso-1-PtLL'; L,L' = Cl or L = H2O and L' = OSO3) are highly effective towards hormone-sensitive, rodent breast cancers due to their significant estrogenic potencies.